Shenzhen Weigong Technology
Latest round
- Series B
Last raised
- Jan 2022
Total raised
- $15M
Investors
- 7
About Shenzhen Weigong Technology
Based in Shenzhen, China and established in 2016, Shenzhen Weigong Technology is a company that engages in research and development of in-vitro diagnostic reagents and medical equipment. The company has three subsidiaries in Shenzhen, Beijing, and Hunan that the subsidiary in Beijing is R&D center, and other subsidiaries are production base. The company's founder is Dr. Weigong Li, who served in the company of BCI, and SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO LTD, and has R&D of experience in blood cell analysis instrument, and flow analysis instrument. The company mainly provides flow cytometry automated equipment and high-throughput fluorescence immunoassay technology. The company's high-throughput fluorescence immunoassay technology can support simultaneously testing over 100 test items in one test tube. It also provides supporting lymphocyte subsets, cytokines, sperm function testing reagents, and client software with automatic analysis functions and two-way information transmission functions. As of January 2022, the company is developing a universal automatic fluorescence immunoassay analyzer with a detection speed of at least 1200 items per hour. It is expected to be available in the first half of 2022. Moreover, the company will promote the detection of autoimmune diseases, and allergens from qualitative to quantitative detection.
Who invested in Shenzhen Weigong Technology
7 investors across 4 rounds
See all investors in Shenzhen Weigong Technology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Shenzhen Weigong Technology
Who invested in Shenzhen Weigong Technology?
Shenzhen Weigong Technology has 7 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Shenzhen Weigong Technology raised?
Shenzhen Weigong Technology has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Shenzhen Weigong Technology last raise money?
Shenzhen Weigong Technology's most recent round on record is a Series B, in Jan 2022.
What does Shenzhen Weigong Technology do?
Based in Shenzhen, China and established in 2016, Shenzhen Weigong Technology is a company that engages in research and development of in-vitro diagnostic reagents and medical equipment.
Where is Shenzhen Weigong Technology headquartered?
Shenzhen Weigong Technology is headquartered in Shenzhen, China.
Which VCs invest in companies like Shenzhen Weigong Technology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back medical devices & equipment companies at Shenzhen Weigong Technology's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Shenzhen Weigong Technology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.